Entity
  • Kimialys

    Created in 2020
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    2,390
  • Activities

  • Technologies

  • Entity types

  • Location

    Paris, France

    Paris

    France

  • Employees

    Scale: 11-50

    Estimated: 18

  • Engaged corporates

    15
    4 8
  • Added in Motherbase

    1 year, 1 month ago
Description
  • Value proposition

    Innovative biosensing solutions for diagnostic and pharmaceutical companies, leveraging our K-One® surface chemistry.

    We are a team of chemists and biosensor engineers gathered around a common mission: shaping the future of biodetection for a better world.

    Kimialys is the result of 10 years of meticulous academic research in surface chemistry. Controlling what is happening on the surface is a fundamental aspect of biosensing techniques such as rapid tests, point-of-care diagnostics, and real-time sensors. Without the right surface interactions, even the most advanced biosensors can falter, leading to misleading results. Our research efforts have always been to optimize these crucial parameters, ensuring both precision and reliable biodetection.

    Founded in 2020, Kimialys is leading the charge in harnessing surface chemistry to revolutionize diagnostics and drug development, all supported by our patented K-One® technology. Building on this foundation, our coated gold nanoparticles elevate rapid diagnostic tests in terms of sensitivity, specificity and reproducibility. Additionally, our expertise in sensor chip functionalisation combined with our expertise in Surface Plasmon Resonance analysis empowers us to detect, screen, and select the most suitable biologics for both diagnostic and therapeutic applications.

    Reliability, robustness, and adaptability are not just benefits of our technology; they are the cornerstones of the relationships we build.
    For every customer we collaborate with, thousands of patients stand to benefit from our work.

  • Kimialys - Innovative biosensing solutions

    We develop advanced gold bioconjugates for IVD and offer biomolecule screening & characterization services, leveraging our K-One® surface chemistry.

  • https://www.kimialys.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Ministère de l'Agriculture et de la Souveraineté alimentaire Ministère de l'Agriculture et de la Souveraineté alimentaire
Government Administration
Other

21 Nov 2024


UK Atomic Energy Authority
UK Atomic Energy Authority
Research, National and local authorities
UK Atomic Energy Authority
Research, National and local authorities
Other

21 Nov 2024


AXELERA
AXELERA
Public business cluster, French Cluster, Chemical Manufacturing
AXELERA
Public business cluster, French Cluster, Chemical Manufacturing
Other

13 Oct 2024


Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Other

16 Sep 2024


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

16 Sep 2024


Roche
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Other

16 Sep 2024


Paris Biotech Santé
Paris Biotech Santé
Startup accelerator & VC, Civic and Social Organizations
Paris Biotech Santé
Startup accelerator & VC, Civic and Social Organizations
Other

2 Jun 2024


RIVP
RIVP
Real Estate, Social Housing
RIVP
Real Estate, Social Housing
Other

2 Jun 2024


J'aime les Startups
J'aime les Startups
NGO, Think Tank, Technology, Information and Internet
J'aime les Startups
NGO, Think Tank, Technology, Information and Internet
Other

16 Apr 2024


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

13 Oct 2024


Similar entities
Loading...
Loading...
Social network dynamics